Christoph Beglinger
Effect of Laparoscopic Sleeve Gastrectomy vs Laparoscopic Roux-en-Y Gastric Bypass on Weight Loss in Patients With Morbid Obesity: The SM-BOSS Randomized Clinical Trial
Peterli R, Nett P, Schiesser M, Drewe J, Beglinger C, Schultes B, Borbély Y, Kröll D, Vetter D, Peters T, Wölnerhanssen B, Bueter M. Effect of Laparoscopic Sleeve Gastrectomy vs Laparoscopic Roux-en-Y Gastric Bypass on Weight Loss in Patients With Morbid Obesity: The SM-BOSS Randomized Clinical Trial. JAMA 2018; 319:255-265.
16.01.2018Effect of Laparoscopic Sleeve Gastrectomy vs Laparoscopic Roux-en-Y Gastric Bypass on Weight Loss in Patients With Morbid Obesity: The SM-BOSS Randomized Clinical Trial
16.01.2018JAMA 2018; 319:255-265
Peterli Ralph, Nett Philipp, Schiesser Marc, Drewe Jürgen, Beglinger Christoph, Schultes Bernd, Borbély Yves, Kröll Dino, Vetter Diana, Peters Thomas, Wölnerhanssen Bettina Karin, Bueter Marco
Laparoscopic Sleeve Gastrectomy Versus Roux-Y-Gastric Bypass for Morbid Obesity-3-Year Outcomes of the Prospective Randomized Swiss Multicenter Bypass Or Sleeve Study (SM-BOSS)
Peterli R, Drewe J, Beglinger C, Schultes B, Schiesser M, Peters T, Borbély Y, Gass M, Nett P, Vetter D, Wölnerhanssen B, Bueter M. Laparoscopic Sleeve Gastrectomy Versus Roux-Y-Gastric Bypass for Morbid Obesity-3-Year Outcomes of the Prospective Randomized Swiss Multicenter Bypass Or Sleeve Study (SM-BOSS). Ann Surg 2017; 265:466-473.
01.03.2017Laparoscopic Sleeve Gastrectomy Versus Roux-Y-Gastric Bypass for Morbid Obesity-3-Year Outcomes of the Prospective Randomized Swiss Multicenter Bypass Or Sleeve Study (SM-BOSS)
01.03.2017Ann Surg 2017; 265:466-473
Peterli Ralph, Drewe Juergen, Beglinger Christoph, Schultes Bernd, Schiesser Marc, Peters Thomas, Borbély Yves, Gass Markus, Nett Philipp, Vetter Diana, Wölnerhanssen Bettina Karin, Bueter Marco
Development and Clinical Validation of a Blood Test Based on 29-Gene Expression for Early Detection of Colorectal Cancer
Ciarloni L, Rüegg C, Maerten P, Vallet C, Beglinger C, Borovicka J, Meier R, van der Weg B, Kim T, Song S, Kim J, Myung S, Nichita C, Monnier-Benoit S, Imaizumi N, Ehrensberger S, Dorta G. Development and Clinical Validation of a Blood Test Based on 29-Gene Expression for Early Detection of Colorectal Cancer. Clin Cancer Res 2016; 22:4604-11.
28.04.2016Development and Clinical Validation of a Blood Test Based on 29-Gene Expression for Early Detection of Colorectal Cancer
28.04.2016Clin Cancer Res 2016; 22:4604-11
Ciarloni Laura, Rüegg Curzio, Maerten Philippe, Vallet Cédric, Beglinger Christoph, Borovicka Jan, Meier Rémy, van der Weg Boudewijn, Kim Tae Il, Song Si Young, Kim Joo Sung, Myung Seung-Jae, Nichita Cristina, Monnier-Benoit Sylvain, Imaizumi Natsuko, Ehrensberger Sahar Hosseinian, Dorta Gian
Monitoring colonoscopy withdrawal time significantly improves the adenoma detection rate and the performance of endoscopists
Vavricka S, Rogler G, Safroneeva E, Peter S, Beglinger C, Biedermann L, Manz M, Rechner R, Degen L, Sulz M, Schoepfer A. Monitoring colonoscopy withdrawal time significantly improves the adenoma detection rate and the performance of endoscopists. Endoscopy 2016
25.01.2016Monitoring colonoscopy withdrawal time significantly improves the adenoma detection rate and the performance of endoscopists
25.01.2016Endoscopy 2016
Vavricka Stephan R, Rogler Gerhard, Safroneeva Ekaterina, Peter Shajan, Beglinger Christoph, Biedermann Luc, Manz Michael, Rechner Roman, Degen Lukas, Sulz Michael, Schoepfer Alain M
Sleep Disruption and Daytime Sleepiness Correlating with Disease Severity and Insulin Resistance in Non-Alcoholic Fatty Liver Disease: A Comparison with Healthy Controls
Bernsmeier C, Weisskopf D, Pflueger M, Mosimann J, Campana B, Terracciano L, Beglinger C, Heim M, Cajochen C. Sleep Disruption and Daytime Sleepiness Correlating with Disease Severity and Insulin Resistance in Non-Alcoholic Fatty Liver Disease: A Comparison with Healthy Controls. PloS one 2015; 10:e0143293.
17.11.2015Sleep Disruption and Daytime Sleepiness Correlating with Disease Severity and Insulin Resistance in Non-Alcoholic Fatty Liver Disease: A Comparison with Healthy Controls
17.11.2015PloS one 2015; 10:e0143293
Bernsmeier Christine, Weisskopf Diego M, Pflueger Marlon O, Mosimann Jan, Campana Benedetta, Terracciano Luigi, Beglinger Christoph, Heim Markus H, Cajochen Christian
Glucose-induced glucagon-like Peptide 1 secretion is deficient in patients with non-alcoholic fatty liver disease
Bernsmeier C, Meyer-Gerspach A, Blaser L, Jeker L, Steinert R, Heim M, Beglinger C. Glucose-induced glucagon-like Peptide 1 secretion is deficient in patients with non-alcoholic fatty liver disease. PloS one 2014; 9:e87488.
29.01.2014Glucose-induced glucagon-like Peptide 1 secretion is deficient in patients with non-alcoholic fatty liver disease
29.01.2014PloS one 2014; 9:e87488
Bernsmeier Christine, Meyer-Gerspach Anne C, Blaser Lea S, Jeker Lia, Steinert Robert E, Heim Markus H, Beglinger Christoph
Prevalence and risk factors of hepatitis B and C virus infections in an impoverished urban community in Dhaka, Bangladesh
Ashraf H, Beglinger C, Hassan M, Salam M, Hossain L, Bardhan P, Brooks A, Rothermundt C, Alam N, Gyr N. Prevalence and risk factors of hepatitis B and C virus infections in an impoverished urban community in Dhaka, Bangladesh. BMC Infect Dis 2010; 10:208.
15.07.2010Prevalence and risk factors of hepatitis B and C virus infections in an impoverished urban community in Dhaka, Bangladesh
15.07.2010BMC Infect Dis 2010; 10:208
Ashraf Hasan, Beglinger Christoph, Hassan Mohammed S, Salam Mohammed A, Hossain Lokman, Bardhan Pradip, Brooks Abdullah, Rothermundt Christian, Alam Nur H, Gyr Niklaus
Natürliche Chromoendoskopie
Sawatzki M, Beglinger C, Lugli A, Manz M. Natürliche Chromoendoskopie. Schweiz Med Forum 2010; 10:139.
01.01.2010Natürliche Chromoendoskopie
01.01.2010Schweiz Med Forum 2010; 10:139
Sawatzki Mikael, Beglinger Christoph, Lugli Alessandro, Manz Michael